Annisa Ristya Rahmanti

Ms. Annisa Ristya Rahmanti

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2021 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
ARAnnisa Ristya Rahmanti
Annisa Ristya Rahmanti
Dina Nur Anggraini NingrumDina Nur Anggraini Ningrum
Dina Nur Anggraini Ningrum
LLLutfan Lazuardi
Lutfan Lazuardi
HYHsuan-Chia Yang
Hsuan-Chia Yang
YLYu-Chuan (Jack) Li
Yu-Chuan (Jack) Li

12 March 2023 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
CHChih-Wei Huang
Chih-Wei Huang
BWBethany C.Y. Wu
Bethany C.Y. Wu
PNPhung-Anh Nguyen
Phung-Anh Nguyen
HWHsiao-Han Wang
Hsiao-Han Wang
CKChih-Chung Kao
Chih-Chung Kao
YLYu-Chuan (Jack) Li
Yu-Chuan (Jack) Li

4 March 2022 in Journal of Medical Internet Research
Verified
Journal Article
Open access
HYHsuan-Chia Yang
Hsuan-Chia Yang
ARAnnisa Ristya Rahmanti
Annisa Ristya Rahmanti
Chih-Wei HuangChih-Wei Huang
Chih-Wei Huang
YLYu-Chuan (Jack) Li
Yu-Chuan (Jack) Li
We propose the idea of using an open data set of doctor-patient interactions to develop artificial empathy based on facial emotion recognition. Facial emotion recognition allows a doctor to analyze patients' emotions, so that they can reach out to their patients through empathic care. However, face recognition data sets are often difficult to acquire; many researchers struggle with small samples of face recognition data sets. Further, sharing medical images or videos has not been possible, as this approach may violate patient privacy. The use of deepfake technology is a promising approach to deidentifying video recordings of patients’ clinical encounters. Such technology can revolutionize the implementation of facial emotion recognition by replacing a patient's face in an image or video with an unrecognizable face—one with a facial expression that is similar to that of the original. This technology will further enhance the potential use of artificial empathy in helping doctors provide empathic care to achieve good doctor-patient therapeutic relationships, and this may result in better patient satisfaction and adherence to treatment.

27 April 2022 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
ARAnnisa Ristya Rahmanti
Annisa Ristya Rahmanti
CCChia-Hui Chien
Chia-Hui Chien
ANAldilas Achmad Nursetyo
Aldilas Achmad Nursetyo
AHAtina Husnayain
Atina Husnayain
Bayu satria WiratamaBayu satria Wiratama
Bayu satria Wiratama
YLYu-Chuan (Jack) Li
Yu-Chuan (Jack) Li

8 May 2025 in Medical Education Online
Verified
Journal Article
Open access
ARAnnisa Ristya Rahmanti
Annisa Ristya Rahmanti
HYHsuan-Chia Yang
Hsuan-Chia Yang
Chih-Wei HuangChih-Wei Huang
Chih-Wei Huang
CHChing-Tzu Huang
Ching-Tzu Huang
LLLutfan Lazuardi
Lutfan Lazuardi
YLYu-Chuan (Jack) Li
Yu-Chuan (Jack) Li
Nonverbal communication is essential in physician-patient interaction, especially in telemedicine where verbal cues may be limited. This study aimed to identify and validate key nonverbal cues for assessing physician empathy in telemedicine consultations through a Delphi method. A three-round Delphi study was conducted from June to November 2022, involving various experts, including academics, healthcare professionals, AI/telemedicine researchers, industry professionals, and patients. Experts evaluated the importance, validity, and reliability of potential nonverbal cues. Consensus was determined based on median responses and expert scoring percentages, with statistical agreement and stability assessed using Kendall's coefficient of concordance (Kendall's W) and Wilcoxon signed-rank test. Analyses were conducted using SPSS, version 23.0 with significance set at p < 0.05. Of the 72 experts invited, 37 (51%) agreed to participate, with 35 completing the first round (95% completion rate). Eight significant nonverbal cues were identified in the first round, though one did not reach consensus. The second round obtained an 89% response rate (31/35), with three new cues introduced; one did not reach consensus. Round 3 achieved a 94% response rate (29/31), finalizing nine key cues: facial expression, eye contact, tone of voice, smiling, head nodding, body posture, hand gesture, distance, and environmental cues. Among these, facial expression, eye contact, and tone of voice were identified as the most crucial. Inter-expert agreement was statistically significant across all items with strong agreement on the importance (W = 0.739, p < 0.001), good agreement on their validity (W = 0.689, p < 0.001), and moderate agreement on their reliability (W = 0.452, p < 0.001). This study highlights the importance of specific nonverbal cues in telemedicine, particularly facial expression, eye contact, and tone of voice. It provides a validated foundation for developing tools to enhance physician-patient interactions and potentially improve health outcomes in telemedicine.

25 February 2022 in Cancers
Verified
Journal Article
Open access
PDF file
CWChing-Huan Wang
Ching-Huan Wang
Chih-Wei HuangChih-Wei Huang
Chih-Wei Huang
PNPhung-Anh Nguyen
Phung-Anh Nguyen
MLMing-Chin Lin
Ming-Chin Lin
CYChih-Yang Yeh
Chih-Yang Yeh
HYHsuan-Chia Yang
Hsuan-Chia Yang
Despite previous studies on statins, aspirin, metformin, and angiotensin-converting-enzyme inhibitors (ACEIs)/angiotensin II receptor blockers (ARBs), little has been studied about all their possible combinations for chemoprevention against cancers. This study aimed to comprehensively analyze the composite chemopreventive effects of all the combinations. In this case-control study, health records were retrieved from claims databases of Taiwan’s Health and Welfare Data Science Center. Eligible cases were matched at a 1:4 ratio with controls for age and sex. Both cases and controls were categorized into 16 exposure groups based on medication use. A total of 601,733 cancer cases were identified. Cancer risks (denoted by adjusted odds ratio; 99% confidence interval) were found to be significantly decreased: overall risk of all cancers in statin-alone (0.864; 0.843, 0.886), aspirin-alone (0.949; 0.939, 0.958), and ACEIs/ARBs (0.982; 0.978, 0.985) users; prostate (0.924; 0.889, 0.962) and female breast (0.967; 0.936, 1.000) cancers in metformin-alone users; gastrointestinal, lung, and liver cancers in aspirin and/or ACEIs/ARBs users; and liver cancer (0.433; 0.398, 0.471) in statin users. In conclusion, the results found no synergistic effect of multiple use of these agents on cancer prevention. Use of two (statins and aspirin, statins and metformin, statins and ACEIs/ARBs, and aspirin and ACEIS/ARBs) showed chemopreventive effects in some combinations, while the use of four, in general, did not.